학술논문

The &agr;5 subunit containing GABAA receptors contribute to chronic pain
Document Type
article
Source
Pain. 157(3)
Subject
Biomedical and Clinical Sciences
Neurosciences
Clinical Sciences
Chronic Pain
Neurodegenerative
Pain Research
2.1 Biological and endogenous factors
Aetiology
Neurological
Animals
Female
Fluorobenzenes
Hyperalgesia
Imidazoles
Injections
Spinal
Pain Measurement
Protein Subunits
Rats
Rats
Wistar
Receptors
GABA-A
Spinal Cord
Triazoles
Chronic pain
GABA(A) receptors
alpha(5) subunit-containing GABA(A) receptors
Secondary allodynia
Secondary hyperalgesia
Rate-dependent depression
Loss of inhibition
Medical and Health Sciences
Psychology and Cognitive Sciences
Anesthesiology
Biomedical and clinical sciences
Health sciences
Psychology
Language
Abstract
It has been recently proposed that α5-subunit containing GABAA receptors (α5-GABAA receptors) that mediate tonic inhibition might be involved in pain. The purpose of this study was to investigate the contribution of α5-GABAA receptors in the loss of GABAergic inhibition and in formalin-induced, complete Freund's adjuvant (CFA)-induced and L5 and L6 spinal nerve ligation-induced long-lasting hypersensitivity. Formalin or CFA injection and L5 and L6 spinal nerve ligation produced long-lasting allodynia and hyperalgesia. Moreover, formalin injection impaired the rate-dependent depression of the Hofmann reflex. Peripheral and intrathecal pretreatment or post-treatment with the α5-GABAA receptor antagonist, L-655,708 (0.15-15 nmol), prevented and reversed, respectively, these long-lasting behaviors. Formalin injection increased α5-GABAA receptor mRNA expression in the spinal cord and dorsal root ganglia (DRG) mainly at 3 days. The α5-GABAA receptors were localized in the dorsal spinal cord and DRG colabeling with NeuN, CGRP, and IB4 which suggests their presence in peptidergic and nonpeptidergic neurons. These receptors were found mainly in small and medium sized neurons. Formalin injection enhanced α5-GABAA receptor fluorescence intensity in spinal cord and DRG at 3 and 6 days. Intrathecal administration of L-655,708 (15 nmol) prevented and reversed formalin-induced impairment of rate-dependent depression. These results suggest that α5-GABAA receptors play a role in the loss of GABAergic inhibition and contribute to long-lasting secondary allodynia and hyperalgesia.